Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pipeleers

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Journal of Proteomics|January 23, 2013
LC-MS/MS identification of doublecortin as abundant beta cell-selective protein discharged by damaged beta cells in vitroL Jiang, B Brackeva, G Stangé, et al.
Diabetologia|March 13, 2010
Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell massB Keymeulen, M Walter, C Mathieu, et al.
Diabetologia|January 22, 2010
Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trialsJ De Grijse, M Asanghanwa, B Nouthe, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Journal of Proteomics|January 23, 2013
LC-MS/MS identification of doublecortin as abundant beta cell-selective protein discharged by damaged beta cells in vitroL Jiang, B Brackeva, G Stangé, et al.
Diabetologia|March 13, 2010
Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell massB Keymeulen, M Walter, C Mathieu, et al.
Diabetologia|January 22, 2010
Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trialsJ De Grijse, M Asanghanwa, B Nouthe, et al.
Pageof 8